Azalpho Injection
Marketer
Arechar Healthcare
Salt Composition
Azacitidine (100mg)
Overview Azalpho Injection
Azalpho Injection treats specific blood cancers, notably all Myelodysplastic Syndrome (MDS) subtypes in adults. Other uses are determined by a physician. Administered intravenously under medical supervision, the dosage and frequency are individualized by your doctor based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can have severe consequences. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only upon your doctor's instruction. Common side effects include injection site inflammation (pain, swelling, redness), nausea, vomiting, and fatigue. Report any concerning side effects to your physician; management strategies may be available. Vaccination during treatment requires prior physician consultation. Regular blood tests monitoring blood cell counts, as well as liver, kidney, and heart function are mandatory. Disclose any pre-existing liver or kidney conditions, or the use of any other medications, particularly antibiotics, prior to commencing treatment. Interactions with other drugs are possible; inform your doctor of all current medications. Azalpho Injection is contraindicated during pregnancy and lactation.
Uses of Azalpho Injection
Myelodysplastic syndrome: Blood cancer therapies
Major Benefits of Azalpho Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Azalpho Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Azalpho Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Azalpho Injection works:
Azalpho Injection is a cancer treatment that disrupts the genetic replication (DNA and RNA) within leukemia cells. This action leads to cell death and promotes the healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Azalpho Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Azalpho Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is recommended.
Breast feedingUNSAFE
Administering Azalpho Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Azalpho Injection may induce adverse reactions that could impair driving ability. Fatigue is one such possible side effect of Azalpho Injection, potentially affecting driving safety.
KidneyCAUTION
Azalpho Injection requires careful administration for individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Azalpho Injection requires careful administration for individuals with hepatic impairment. Dosage modification of Azalpho Injection might be necessary. Physician consultation is advised. Azalpho Injection is contraindicated in patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take Azalpho Injection :
NA
Facts to Know About Azalpho Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently